ライフサイエンスコーパス: bacterial infection

1 l, and can protect mice against a subsequent bacterial infection.

2 m signaling to modulate the host response to bacterial infection.

3 ing to host defense against enteropathogenic bacterial infection.

4 ood and impaired control of tumor growth and bacterial infection.

5 ucial innate-adaptive immune link to control bacterial infection.

6 ng reduced T cell activation during viral or bacterial infection.

7 in genetically programmed susceptibility to bacterial infection.

8 ed ROS production, and are more resistant to bacterial infection.

9 ation, hydrogels are at an increased risk of bacterial infection.

10 y tract of transgenic mice upon induction by bacterial infection.

11 was infused with no adverse side effects or bacterial infection.

12 te decision in their steady state and during bacterial infection.

13 VPA could affect the course of intracellular bacterial infection.

14 bited reduced virulence in a murine model of bacterial infection.

15 commensal microflora and combating invasive bacterial infection.

16 NF-kappaB signalling in the initial phase of bacterial infection.

17 talk in the marginal zone (MZ) that promoted bacterial infection.

18 ved in many diseases and disorders including bacterial infection.

19 does not increase susceptibility to viral or bacterial infection.

20 means of nutritional self-medication against bacterial infection.

21 evels of markers of lipid peroxidation after bacterial infection.

22 ization affects the host response to chronic bacterial infection.

23 ate phase and is not solely a consequence of bacterial infection.

24 1 regulates TLR4-induced inflammation during bacterial infection.

25 infections with CAP 3 was able to clear the bacterial infection.

26 ead to gut bacterial translocation (GBT) and bacterial infection.

27 usceptibility of these individuals to severe bacterial infection.

28 uced miR-31 levels were useful predictors of bacterial infection.

29 le of B cells in TLR7-mediated resistance to bacterial infection.

30 e of KDM3C in inflammatory responses to oral bacterial infection.

31 r communication for maximizing the spread of bacterial infection.

32 e proinflammatory response of macrophages to bacterial infection.

33 lts were reproducible at 3 and 10 days after bacterial infection.

34 ant functions and play multifaceted roles in bacterial infection.

35 as been limited research focused on maternal bacterial infection.

36 cellular activities and host responses upon bacterial infection.

37 gonists improve the response of P47S mice to bacterial infection.

38 ing an important function of this protein in bacterial infection.

39 oteolytic activity of Lon-1 is essential for bacterial infection.

40 trol of macrophage activation in response to bacterial infection.

41 R1A decreases MAIT cell activation following bacterial infection.

42 delta2 T cells in a humanized mouse model of bacterial infection.

43 crease in the incidence of possible maternal bacterial infection.

44 erculosis is the leading cause of death from bacterial infection.

45 utes to host resistance or susceptibility to bacterial infection.

46 ate associated with these difficult-to-treat bacterial infections.

47 opment of non-chemical treatment options for bacterial infections.

48 nterim effective protection against emerging bacterial infections.

49 ses the difficulty for clinical treatment of bacterial infections.

50 otease inhibitors, which might help to fight bacterial infections.

51 nodule organogenesis and the progression of bacterial infections.

52 UTIs are amongst the most frequent bacterial infections.

53 795 participants, 1414 developed 1883 severe bacterial infections.

54 on therapies for treatment of drug-resistant bacterial infections.

55 peutic strategies that tackle persistence in bacterial infections.

56 d for devising targeted strategies to combat bacterial infections.

57 es the radiotracers as applied to imaging of bacterial infections.

58 tify a promising new cyclic analogue against bacterial infections.

59 lization for evaluation of possible invasive bacterial infections.

60 eatment of multidrug resistant Gram-negative bacterial infections.

61 lop alternatives to prevent and combat these bacterial infections.

62 possible approach to treat biofilm-dependent bacterial infections.

63 , when we are looking for new ways to target bacterial infections.

64 acological drug development and treatment of bacterial infections.

65 ey regulator of blood clotting during lethal bacterial infections.

66 ies are needed to treat antibiotic-resistant bacterial infections.

67 class of antibiotics ever developed against bacterial infections.

68 nergy between influenza virus infections and bacterial infections.

69 new tools that can be used to combat deadly bacterial infections.

70 role in recognizing tumor cells and viral or bacterial infections.

71 ssential for the treatment of drug-resistant bacterial infections.

72 ith decompensated cirrhosis with and without bacterial infections.

73 to the establishment of long-lasting chronic bacterial infections.

74 potential therapeutic target for controlling bacterial infections.

75 y, responsible for the recalcitrance of many bacterial infections.

76 ting innate immunity to combat Gram-negative bacterial infections.

77 ed the development of alternatives to combat bacterial infections.

78 drugs in different human diseases including bacterial infections.

79 proaches for the treatment of drug-resistant bacterial infections.

80 l role in the innate immune system defending bacterial infections.

81 s and treatment of multidrug resistant (MDR) bacterial infections.

82 ost defenses and increases susceptibility to bacterial infections.

83 cination or antibody-based therapies against bacterial infections.

84 ion, and thus are promising in circumventing bacterial infections.

85 s to combat and prevent antibiotic-resistant bacterial infections.

86 tes with carbapenem-resistant, Gram-negative bacterial infections.

87 to human and livestock health when treating bacterial infections.

88 eatment for serious and antibiotic-resistant bacterial infections.

89 ssess safety for topical application against bacterial infections.

90 ers broad-spectrum protection against lethal bacterial infections.

91 iotic prescription rates varied for presumed bacterial infections (0.9 to 1.1), presumed viral infect

92 portant orchestrators of inflammation during bacterial infection, acting as both effector cells and r

93 igms underlying miRNA-mediated regulation of bacterial infection, acting as part of the host response

94 These results indicate that bacterial infection, acting in part through the NPC, alt

95 s nearly twice that of less severe localized bacterial infection (adjusted odds ratio=1.6, 95% CI=1.1

96 The effect of multisystemic bacterial infection (adjusted odds ratio=2.9, 95% CI=1.3

97 points, 120 (23%) and 87 (16%) experienced a bacterial infection and 22 (4%) and 55 (10%) experienced

98 ion of DC immune functions required to clear bacterial infection and activate T cell effector respons

99 h elevated activity in lung diseases such as bacterial infection and alpha-1 antitrypsin deficiency.

100 nse to diverse stresses including pathogenic bacterial infection and chemical and mechanical insult.

101 exhibit chromogenic reactions, resistance to bacterial infection and heat-triggered, enzyme-assisted

102 yclic dinucleotides that are released during bacterial infection and in endogenous cyclic GMP-AMP sig

103 racts with CFTR under nutritional stress and bacterial infection and incorporates it into mature auto

104 fficking of various leukocytes into sites of bacterial infection and inflammation.

105 ased, NTS remained a major cause of invasive bacterial infection and mortality among hospitalized chi

106 Taken together, our results link bacterial infection and NF-kappaB-driven innate immune r

107 Th17-polarized settings of acute and chronic bacterial infection and of tumor growth that the conditi

108 on, GBPs customize inflammasome responses to bacterial infection and sepsis, where they act as critic

109 imaging techniques used for the diagnosis of bacterial infection and their roles in different clinica

110 resistance phenotypes, during Gram-negative bacterial infection and will advance our understanding o

111 minent in the early phase of acute viral and bacterial infections and a molecularly distinct Blimp1(l

112 MDS patients have recurrent bacterial infections and abnormal expression of CD56 by

113 sponses, and we propose a novel link between bacterial infections and autoimmune diseases.

114 recognizes and responds to threats early in bacterial infections and can influence the downstream im

115 Bacterial infections and collagen diseases were excluded

116 ity tests adversely affects the treatment of bacterial infections and contributes to increased preval

117 cal hints for host response to Gram-negative bacterial infections and development of different inflam

118 ic fibrosis (CF) is characterized by chronic bacterial infections and heightened inflammation.

119 genes, raises the possibility of untreatable bacterial infections and motivates the development of im

120 -to-handle system for the study of viral and bacterial infections and other aspects of tick cellular

121 t C3 deficiency is associated with recurrent bacterial infections and proliferative glomerulonephriti

122 ymphoid organ immunity in regulating chronic bacterial infections and provides further evidence for t

123 arvae have impaired recruitment to localized bacterial infections and reduced survival that is, at le

124 physiological roles of TCP96 in controlling bacterial infections and reducing LPS-induced inflammati

125 g adults with primary discharge diagnoses of bacterial infections and secondary SUD diagnoses, using

126 rating antimicrobial amyloids in response to bacterial infection, and (3) ExoY contributes to the vir

127 for diagnostic imaging of obesity/diabetes, bacterial infection, and cancer.

128 holyase targets, profiling the biomarkers of bacterial infection, and developing enzyme-mediated stra

129 other disease pathologies including cancer, bacterial infections, and neurodegeneration.

130 effects of this communication during enteric bacterial infection are only beginning to be characteriz

131 Enteropathogenic bacterial infections are a global health issue associate

132 Gram-negative bacterial infections are a significant public health con

133 Bacterial infections are affected by time of day, but th

134 Secondary bacterial infections are an important cause of morbidity

135 Multidrug resistant Gram-negative bacterial infections are an increasing public health thr

136 Chronic bacterial infections are caused by pathogens that persis

137 Bacterial infections are causing worldwide morbidity and

138 Bacteremia and other invasive bacterial infections are common among children with canc

139 Bacterial infections are frequently based on the binding

140 ntimicrobial resistance, novel ways to treat bacterial infections are required and the use of predato

141 Severe bacterial infections are the first cause of morbidity in

142 ould distinguish typhoid from other invasive bacterial infections (area under the receiver operating

143 Antibiotic-resistant bacterial infections arising from acquired resistance an

144 We generated endodontic disease mice through bacterial infection as an inflammatory disease model and

145 mice exhibited enhanced resistance to nasal bacterial infection as the transgenic mice showed a high

146 different in vivo mouse models of viral and bacterial infection as well as protective vaccination, w

147 ole of hospital-acquired multidrug-resistant bacterial infections as the leading immediate cause of n

148 associated with an increased risk of severe bacterial infection, as were neutrophil function-alterin

149 by which nanomaterials can be used to target bacterial infections associated with acquired antibiotic

150 ng factor to the increased susceptibility to bacterial infections associated with higher morbidity an

151 effective in the treatment of Gram-negative bacterial infections associated with urinary, respirator

152 hritis' (APSGN) was the prototypical form of bacterial infection-associated glomerulonephritis, typic

153 d paper devices for timely identification of bacterial infections at the point-of-care and their usef

154 aladaptive response to acute inflammation or bacterial infection based on compelling recent basic res

155 arget for vaccine-induced protection against bacterial infections because of their rapid cytotoxic re

156 have the potential to manage a wide range of bacterial infections because the target enzymes are impl

157 les medical professionals to act promptly on bacterial infection before biofilms get fully establishe

158 Type I and III IFNs play diverse roles in bacterial infections, being protective for some but dele

159 homoserine lactone (199 Da), a gram-negative bacterial infection biomarker.

160 ntibiotics used for the treatment of serious bacterial infections but have use-limiting side effects

161 This leads to more productive intracellular bacterial infections but is protective against malarial

162 atment of carbapenem-resistant Gram-negative bacterial infections, but polymyxin resistance is increa

163 tribute to host-defense responses in certain bacterial infections, but their role in skin wound super

164 uman cells, phages can alter the severity of bacterial infections by the dissemination of virulence f

165 e range of multidrug resistant Gram-negative bacterial infections, by both intravenous and oral admin

166 Although bacterial infection can induce IL-17D in fish and invert

167 Dysregulation of the immune response to bacterial infection can lead to sepsis, a condition with

168 infectious diseases such as Lyme disease, a bacterial infection caused by Borrelia burgdorferi in No

169 Enteric fever, a bacterial infection caused by Salmonella enterica seroty

170 ividual animals in the context of a systemic bacterial infection, colitis, and acute graft-versus-hos

171 ith both tissue neutrophilia and symptomatic bacterial infection/colonization in aged patients.

172 gene: c.1811delT (Val604Glyfs*2), recurrent bacterial infections, crescentic glomerulonephritis, and

173 Timely resolution of bacterial infections critically depends on phagocytosis

174 ted interest for the treatment of cancer and bacterial infections due to their critical role in mitoc

175 hors estimated associations between maternal bacterial infection during pregnancy and psychosis risk

176 The authors hypothesized that maternal bacterial infection during pregnancy increases offspring

177 The study findings suggest that maternal bacterial infection during pregnancy is associated with

178 Maternal bacterial infection during pregnancy was strongly associ

179 lop psychosis after maternal exposure to any bacterial infection during pregnancy.

180 apy and magneto-thermal therapy can suppress bacterial infections, excessive heat often damages host

181 irst report concerning the E. coli secondary bacterial infections following the FMD-outbreak.

182 arker could reliably and rapidly distinguish bacterial infection from other, noninfectious causes of

183 he decidual region of the uterus can clear a bacterial infection from the developing fetus by infusio

184 rrelated with bacterial loads in response to bacterial infection, further supporting the significance

185 phage therapy targeting antibiotic-resistant bacterial infections generally.

186 Probable bacterial infection (>105 copies/mL) was detected in 133

187 genes for which increased susceptibility to bacterial infection has been reported.

188 years old with a first invasive encapsulated bacterial infection have a high likelihood of death or r

189 sistance make the treatment of Gram-negative bacterial infections highly challenging.

190 associated with an increased risk of severe bacterial infection (HR = 1.3, 95% CI = 1.1-1.7 for 40-8

191 e malaria patients with concomitant invasive bacterial infections (IBIs) of blood or CSF (GM 312 ng/m

192 airs the host immune response to respiratory bacterial infection in a largely pathogen-independent ma

193 dement combination therapies can eliminate a bacterial infection in cases where each treatment in iso

194 cytosolic double-stranded DNA from viral or bacterial infection in mammalian cells, cyclic dinucleot

195 rties, and its levels swiftly decrease after bacterial infection in mammalian cells, implying a role

196 ls exacerbates macrophage responses to acute bacterial infection in mice, leading to high mortality d

197 rovide not only a new finding of the role of bacterial infection in PCa progression but also potentia

198 fforts that focus on preventing and managing bacterial infection in pregnant women.

199 The improved resistance to bacterial infection in the PG-1 transgenic mice could be

200 unctions included: reducing inflammation and bacterial infection in wound sites, measuring tension of

201 PR activation makes cells more responsive to bacterial infections in a NOD1-dependent manner.

202 (UTIs) in children are among the most common bacterial infections in childhood.

203 promising genetic strategy to prevent airway bacterial infections in farm animals by bacteria-inducib

204 re needed to predict the burden of secondary bacterial infections in future pandemics to inform stock

205 nary tract infection, one of the most common bacterial infections in humans.

206 he rise in frequency of multi-drug-resistant bacterial infections in humans.

207 resort used in treating multi-drug resistant bacterial infections in humans.

208 ages (PMs) regulate inflammation and control bacterial infections in patients with decompensated cirr

209 ded because the rapid rise in drug-resistant bacterial infections in recent decades has been accompan

210 IRF3 is also involved in resistance to some bacterial infections, in anticancer immunity, and in ant

211 ata for microbiologically confirmed invasive bacterial infection including meningitis and AMR among n

212 at added Delphi-selected comorbidities and a bacterial infection indicator was more accurate for all

213 We hypothesized that intrauterine bacterial infection induces changes in microRNA (miRNA)

214 y ligand Upd3, hemocytes act as sentinels of bacterial infection, inducing expression of the antimicr

215 eature of pathological states encountered in bacterial infection, inflammation, wounds, cardiovascula

216 Secondary bacterial infection is associated with more severe sympt

217 ing wound pathology to biofilm properties of bacterial infection is challenging.

218 ent host protection against enteropathogenic bacterial infection is characterized by coordinated resp

219 Early diagnosis of bacterial infections is crucial to improving survival ra

220 Treatment of bacterial infections is increasingly challenged by resis

221 (phages) for the treatment of drug-resistant bacterial infections is one approach that has gained sig

222 The incidence of Lyme disease, a tick-borne bacterial infection, is dramatically increasing in North

223 a cellular stress response to starvation and bacterial infection, is executed by double-membrane-boun

224 umps present a challenge to the treatment of bacterial infections, making it vitally important to und

225 These results suggest that periodontal bacterial infection may cause significant changes in the

226 ssay when differentiation between fungal and bacterial infections might be desirable.

227 During bacterial infection, multiple mouse Gbps, human GBP2, an

228 btained from febrile children with confirmed bacterial infection (n = 20) and confirmed viral infecti

229 rth or neonatal death, and possible maternal bacterial infection; neonatal death alone and stillbirth

230 nt of diseases, including cancers, viral and bacterial infections, neurodegenerative and autoimmune d

231 fer from BMSCs into HSCs, in the response to bacterial infection, occurs before the HSCs activate the

232 We conclude that bacterial infection of the placenta is not a common caus

233 Incidence of whooping cough (pertussis), a bacterial infection of the respiratory tract caused by t

234 redict the antibiotic resistance profiles of bacterial infections of hospitalized patients using mach

235 accurately predict antibiotic resistance of bacterial infections of hospitalized patients.

236 sine has been shown to prevent and eliminate bacterial infections of the respiratory tract, but it is

237 nd function of airway CD4 T(RM) cells during bacterial infection, offering novel strategies for targe

238 ence for sepsis could typically attribute to bacterial infection or bacterial endotoxins, but infecti

239 athogens invade and survive within bone, how bacterial infection or resulting innate immune responses

240 sion and inflammasome priming in response to bacterial infection or TLR stimulation.

241 was identified between IA and posttransplant bacterial infection (OR = 7.51; 95% CI = 4.37-12.91), re

242 rrence of opportunistic infection, recurring bacterial infections, or de novo neoplasia.

243 with beta-thalassaemia increase the risk of bacterial infections, particularly Burkholderia pseudoma

244 ics for the treatment of multidrug-resistant bacterial infections, particularly the ESKAPE pathogens.

245 In the current concept of bacterial infections, pathogen-associated molecular patt

246 e frontier of infection foci and may promote bacterial infection persistence in dynamic epithelia.

247 We found that MDR bacterial infections pose a significant risk to patients

248 Bacterial infections present one of the leading causes o

249 -related mortality is often due to secondary bacterial infections, primarily by pneumococci.

250 on of local mast cells also clears cutaneous bacterial infection, promotes healing, and protects agai

251 tothermal therapy against a wide spectrum of bacterial infections, promoting future biointerface desi

252 e nanoparticle-based approaches to eliminate bacterial infections, providing crucial insight into the

253 Bacterial infections remain a leading threat to global h

254 Bacterial infections remain a major threat to humanity a

255 immune signaling and gene expression during bacterial infection remains largely unknown.

256 members, yet their role in enteropathogenic bacterial infection remains poorly defined.

257 e importance and regulation of TRIM21 during bacterial infection remains poorly understood.

258 Bacterial infection reprograms the genetic architecture

259 Successful management of acute bacterial infections requires early diagnosis and treatm

260 types, to mimic immune responses to viral or bacterial infections, respectively.

261 prevention strategies against intracellular bacterial infections such as brucellosis.

262 However, its contribution in ocular bacterial infections, such as endophthalmitis, which oft

263 Rises in the incidence of bacterial infections, such as infective endocarditis (IE

264 ntestinal epithelial cell (IEC) responses to bacterial infections, such as Salmonella enterica serova

265 l role for FSTL-1 in innate lung immunity to bacterial infection, suggesting that FSTL-1 influences t

266 the olfactory bulb is a distinct barrier to bacterial infection, suggesting that this layer constitu

267 ased therapies are promising tools to combat bacterial infections that are difficult to treat, featur

268 evels of antibiotics increases the spread of bacterial infections that are resistant to treatment in

269 ich have been shown to play central roles in bacterial infections that result in major human diseases

270 es, collecting data from 18 patients without bacterial infections (the Pilot-PRECIOSA study).

271 essential role in regulating coagulation in bacterial infections through a mechanism independent of

272 ed by hypoxia conditions as a consequence of bacterial infection, thus explaining the utilization of

273 include brain-specific risk factors, such as bacterial infection, tissue scarring, inflammation, and

274 s in a Galleria mellonella (insect) model of bacterial infection to create a fully parametrised mathe

275 a major role in the systemic response after bacterial infection to limit its dissemination.

276 as to causatively link biofilm properties of bacterial infection to specific pathogenic mechanisms in

277 health threat, causing routine treatments of bacterial infections to become increasingly difficult.

278 mallei infections and 29 patients with other bacterial infections to validate the test and determine

279 This may be due to ongoing bacterial infection, translocated bacterial products or

280 ents with carbapenem-resistant gram-negative bacterial infections treated with colistin or colistin-m

281 Bacterial infection triggers a cytokine storm that needs

282 ased point-of-care platform for detection of bacterial infection, utilizing smartphone measurement of

283 ng and controlling multidrug-resistant (MDR) bacterial infection via eradiation of bacteria and their

284 = 0.04); the incidence of possible maternal bacterial infection was 4.8% and 6.3%, respectively (rel

285 superiority analyses, and possible maternal bacterial infection was evaluated with a noninferiority

286 f metabolic regulation for host responses to bacterial infection, we challenged insulin pathway mutan

287 has a role in mediating host defense against bacterial infections, we studied i.p. infection by group

288 D within 30 days of transplantation, and all bacterial infections were recognized within 45 days.

289 e most common readout method, and cancer and bacterial infections were the most common therapeutic ar

290 s that can be used to noninvasively diagnose bacterial infections when paired with a molecularly targ

291 symptoms alone do not distinguish viral from bacterial infection which may delay appropriate treatmen

292 with influenza are at high risk of secondary bacterial infection, which is a major proximate cause of

293 pulmonary disease (COPD) are susceptible to bacterial infections, which worsen lung inflammation and

294 5 years with fever and/or suspected invasive bacterial infection who provided consent (38 152 inpatie

295 (+) juveniles exhibited spontaneous neonatal bacterial infections with robust mucoinflammatory featur

296 inal chemists in radiotracer development for bacterial infections, with an emphasis on target selecti

297 ydia is the most common sexually transmitted bacterial infection worldwide.

298 coccus aureus is among the leading causes of bacterial infections worldwide.

299 are among the most common causes of enteric bacterial infections worldwide.

300 the roles of MRGPRX2/B2 in the clearance of bacterial infection, wound healing, periodontal disease,